| Not Yet Recruiting | The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio NCT07476248 | Assiut University | — |
| Not Yet Recruiting | LLM-CoManage: Large Language Model-Enabled Co-Management of Hypertension, Diabetes, and Dyslipidemia NCT07350486 | First Hospital of China Medical University | N/A |
| Not Yet Recruiting | Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD NCT07524101 | Yonsei University | N/A |
| Not Yet Recruiting | Effect of Compound (Cardiol Forte) on Lipid And Glycemic Parameters in Low Cardiovascular Risk Individuals NCT07515573 | U.G.A. Nutraceuticals | N/A |
| Not Yet Recruiting | Community Physical Exercise Program in Chronic Disease NCT06771024 | Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv | N/A |
| Not Yet Recruiting | Implementation Facilitation of Exercise is Medicine Greenville NCT07340580 | University of South Carolina | N/A |
| Not Yet Recruiting | Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study NCT07515560 | Daewoong Pharmaceutical Co. LTD. | — |
| Not Yet Recruiting | Validation of Remote Photoplethysmography (rPPG)-Derived Cardiovascular Parameters Against Standard Clinical M NCT07502703 | Tarumanagara University | — |
| Not Yet Recruiting | Guideline Adherence in Dyslipidemia With Clinical Decision Support NCT07412457 | I.M. Sechenov First Moscow State Medical University | — |
| Not Yet Recruiting | Effect of a Low-Calorie MCT-Rich Traditional Minangkabau Diet on Obese Individuals NCT07423884 | Andalas University | N/A |
| Recruiting | A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Fac NCT07238556 | University of Connecticut | N/A |
| Not Yet Recruiting | The Effects of Rosuvastatin on Running Training Adaptation and Safety NCT07401017 | Taipei Medical University WanFang Hospital | N/A |
| Enrolling By Invitation | Digital Care for Holistic Health in Older Adults With Diabetes and Multimorbidity NCT07310849 | Chang Gung University of Science and Technology | N/A |
| Not Yet Recruiting | To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program Wit NCT07387393 | University of Hawaii | N/A |
| Recruiting | Intermittent Cottonseed Oil Consumption NCT07246408 | University of Georgia | N/A |
| Not Yet Recruiting | Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled NCT07314775 | Xinjiang Uygur Pharmaceutical Co., Ltd. | Phase 4 |
| Not Yet Recruiting | Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity NCT07151430 | Xuanwu Hospital, Beijing | N/A |
| Not Yet Recruiting | Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disord NCT07206875 | IRCCS San Raffaele | — |
| Active Not Recruiting | Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients NCT07268781 | Hasanuddin University | N/A |
| Enrolling By Invitation | EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS NCT07000825 | Universidade Federal da Fronteira Sul | N/A |
| Not Yet Recruiting | Evaluation of an Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Manage NCT07208331 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | — |
| Recruiting | The Effect of a Digital Heart Health App and Lifestyle Intervention for Heart Disease in Primary Care. NCT06919302 | University of Toronto | N/A |
| Recruiting | A Two-arm, Open-label, Single-sequence, Multiple-dose, Cross-over Study to Evaluate the Pharmacokinetic Intera NCT07162441 | Korea United Pharm. Inc. | Phase 1 |
| Enrolling By Invitation | Patient-engaged Development and Testing of Educational Content on Side Effects of Statins NCT07094412 | Weill Medical College of Cornell University | N/A |
| Recruiting | Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial NCT07119658 | Indiana University | N/A |
| Not Yet Recruiting | Effects of a 12-Week Waltz Dance Intervention on Cardiovascular Health in Women Aged 45-65 With Dyslipidemia NCT07061249 | Gdansk University of Physical Education and Sport | N/A |
| Recruiting | Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens NCT07043166 | Shanghai Changzheng Hospital | — |
| Not Yet Recruiting | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HS-10510 in Healthy Subj NCT07001787 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adul NCT06980428 | AstraZeneca | Phase 1 |
| Active Not Recruiting | To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in Healthy Adults NCT06933459 | AJU Pharm Co., Ltd. | Phase 1 |
| Not Yet Recruiting | Implementation and Effectiveness of "CareAide® App" for People with Cardiometabolic Diseases At a Primary Care NCT06779591 | University of Malaya | N/A |
| Recruiting | Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations NCT06935513 | Affiliated Hospital of Nantong University | N/A |
| Not Yet Recruiting | The SWITCH (Substitution of High With Low Ultra-processed Soy Protein Foods In a Guideline-based Diet inTerven NCT06907862 | University of Toronto | N/A |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dysli NCT06955104 | JW Pharmaceutical | Phase 3 |
| Recruiting | Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patient NCT07045623 | Saint Vincent's Hospital, Korea | N/A |
| Completed | Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dysli NCT07094022 | Amway (China) R&D Center | N/A |
| Completed | ALN-APOC3 in Adult Participants With Dyslipidemia NCT06784349 | Regeneron Pharmaceuticals | Phase 1 |
| Recruiting | Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions NCT06676046 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Recruiting | Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Ob NCT07221279 | Kennesaw State University | N/A |
| Active Not Recruiting | Effectiveness of a Mobile Health Management Program for Colorectal Cancer Survivors With Chronic Conditions NCT06759844 | Seoul National University Hospital | N/A |
| Completed | A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Comb NCT06742853 | AstraZeneca | Phase 1 |
| Completed | A Phase I Clinical Study of a Single Subcutaneous Injection of HRS-5632 in Healthy Subjects NCT06732154 | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslip NCT06643130 | JW Pharmaceutical | Phase 3 |
| Completed | Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Health NCT06758661 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Recruiting | Jockey Club Precision Prevention Programme on Young Onset Diabetes NCT06693934 | Juliana CN Chan | N/A |
| Not Yet Recruiting | SCORE! Non-Physician Health Worker (NPHW) Implementation Protocol (SIP) NCT06694987 | Sonia Anand | N/A |
| Active Not Recruiting | Pharmacist Case Finding and Intervention for Vascular Prevention Trial NCT06405880 | University of Alberta | N/A |
| Recruiting | Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 NCT06694012 | Osaka Metropolitan University | — |
| Completed | Lipoprotein (a) and Vascular Regenerative Cell Content NCT06626659 | Canadian Medical and Surgical Knowledge Translation Research Group | — |
| Enrolling By Invitation | Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet NCT06369571 | Johns Hopkins University | Phase 1 / Phase 2 |
| Completed | Weight Inclusive and Adaptive Strategies to Enhance Cardiometabolic Health in Black Adults NCT06284681 | University of Alabama at Birmingham | N/A |
| Recruiting | A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Heal NCT06669429 | Peking University First Hospital | Phase 1 |
| Active Not Recruiting | Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients Wit NCT06832371 | Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) | — |
| Completed | Exercise Impact in Elderly With Multimorbidity: HbA1c and Blood Pressure NCT06879639 | Universidade do Porto | N/A |
| Completed | Advanced Strategy of Food Supplements for the Optimization of Satiety and Lipid Metabolism in Maturity (SACIAN NCT07269795 | University of Alicante | N/A |
| Completed | Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determin NCT06471595 | University of Hawaii | N/A |
| Recruiting | Cottonseed Oil Versus Matched PUFA Effects NCT06382298 | University of Georgia | N/A |
| Recruiting | Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study NCT07447362 | Universidad Católica San Antonio de Murcia | N/A |
| Completed | A Pilot Study of High-Dose Omega-3 (Soloways ™) Polyunsaturated Fatty Acids in Patients with Dyslipidemia Carr NCT06863935 | S.LAB (SOLOWAYS) | N/A |
| Recruiting | Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia NCT06772168 | CMG Pharmaceutical Co. Ltd | Phase 3 |
| Completed | A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipi NCT06173570 | AstraZeneca | Phase 2 |
| Completed | Effect of Bergamot and Plant Sterols Extract on Serum Lipid Profile NCT06929403 | Istanbul Bilgi University | N/A |
| Unknown | Assessment of Epicardial Fat Thickness in Children With Familial Dyslipidemia NCT06101771 | Assiut University | — |
| Unknown | Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia NCT06153433 | Yonsei University | Phase 4 |
| Recruiting | Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia NCT05365425 | Seoul National University Bundang Hospital | Phase 4 |
| Completed | Effect of Omega 3 in Hypertensive Patients NCT06840964 | Santa Maria de la Salud, Argentina | N/A |
| Completed | A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin. NCT05787002 | AstraZeneca | Phase 1 |
| Completed | Chemotherapy-induced Lipid Profile Changes in Women With Early Breast Cancer NCT06958783 | Cancer center Stefan Kukura Hospital Michalovce | — |
| Unknown | Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia NCT04603508 | EMS | Phase 3 |
| Active Not Recruiting | Lipid Balance in Adult Sickle Cell Patients NCT05780775 | Centre Hospitalier Universitaire de la Guadeloupe | N/A |
| Completed | A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin NCT05421078 | NewAmsterdam Pharma | Phase 2 |
| Completed | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD0780 in Healthy Subje NCT05384262 | AstraZeneca | Phase 1 |
| Completed | A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and "Smart Coach" on the Lipid-lowe NCT05370703 | Abbott | — |
| Completed | To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients NCT06866509 | Daewoong Pharmaceutical Co. LTD. | — |
| Completed | To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension NCT05331014 | JW Pharmaceutical | Phase 3 |
| Completed | Effect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese Peop NCT06626867 | Chien-Wen Hou | N/A |
| Completed | An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in NCT05120895 | Daiichi Sankyo | — |
| Completed | Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment NCT03527069 | EMS | Phase 3 |
| Completed | A Study of AZD8233 in Participants With Dyslipidemia. NCT04823611 | AstraZeneca | Phase 1 / Phase 2 |
| Completed | Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis NCT04271735 | National Heart, Lung, and Blood Institute (NHLBI) | N/A |
| Completed | Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR NCT04447820 | Kowa Research Institute, Inc. | Phase 2 |
| Completed | Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events NCT04271280 | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | — |
| Completed | An Observational Study to Evaluate the Treatment of Newvast® Tab(Atorvastatin) in Korean Patients With Dyslipi NCT05555238 | Hanmi Pharmaceutical Company Limited | — |
| Completed | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab NCT05184179 | Daewoong Pharmaceutical Co. LTD. | — |
| Completed | To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Admi NCT04155645 | AstraZeneca | Phase 1 |
| Withdrawn | Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dysli NCT02662894 | EMS | Phase 3 |
| Unknown | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With High Risk Coronary Artery Dise NCT04087915 | Beijing Anzhen Hospital | — |
| Terminated | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy Subjec NCT04055168 | AstraZeneca | Phase 1 |
| Completed | GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL NCT03861533 | Dr. Anatoly Langer | — |
| Unknown | Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study) NCT03606824 | Shaochun.Li | N/A |
| Completed | Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures F NCT06794892 | Azienda Sanitaria Locale Napoli 2 Nord | — |
| Withdrawn | Efficacy of Fixed-doses of Antihypertensive and Statin Drugs NCT03401580 | EMS | Phase 2 |
| Completed | Effect of Intake of Dehydrated Nopal Powder From Highly Mature Cladodes on the Lipid Profile NCT07018908 | Universidad Autónoma de Querétaro | N/A |
| Completed | Dyslipidemia of Obesity Intervention in Teens NCT02956590 | Carelon Research | Phase 3 |
| Completed | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet NCT05450575 | Hanmi Pharmaceutical Company Limited | — |
| Completed | Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension NCT03267329 | Yuhan Corporation | Phase 4 |
| Completed | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 NCT03235362 | Yuhan Corporation | Phase 1 |
| Completed | Metabolic Response to Chardonnay Grape Marc Powder NCT03203915 | USDA, Western Human Nutrition Research Center | N/A |
| Completed | Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia NCT03156842 | Boryung Pharmaceutical Co., Ltd | Phase 3 |
| Completed | Berberine, Chlorogenic Acid and Tocotrienols in Menopause-associated Dyslipidemia NCT03019263 | Fondazione IRCCS Policlinico San Matteo di Pavia | N/A |
| Terminated | Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) NCT03071692 | Kowa Research Institute, Inc. | Phase 3 |
| Terminated | Fourier Open-label Extension Study in Subjects With Clinically Evident Cardiovascular Disease in Selected Euro NCT03080935 | Amgen | Phase 3 |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 NCT03210649 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD NCT02993120 | Amgen | — |
| Unknown | Diabetes Complication Control in Community Clinics (D4C) Trial NCT02835287 | Tulane University | N/A |
| Completed | Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501- NCT03210532 | Daewon Pharmaceutical Co., Ltd. | Phase 3 |
| Unknown | Capsaicin Effect on Cytokines Profile in Dyslipidemia NCT02823912 | University of Guadalajara | Phase 2 / Phase 3 |
| Completed | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Exten NCT02867813 | Amgen | Phase 3 |
| Unknown | Use of Nutrigenomic Models for the Personalized Treatment With Medical Foods in Obese People NCT02837367 | University of Medicine and Pharmacy "Victor Babes" Timisoara | N/A |
| Completed | Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 NCT02982408 | Rigshospitalet, Denmark | N/A |
| Terminated | Bococizumab HIV Evaluation (B-HIVE) Study NCT02524106 | University of California, San Francisco | Phase 3 |
| Completed | Families on Track: A Digital Health Behavioral Intervention for Parents Seeking Treatment for Their Child With NCT02767440 | Duke University | N/A |
| Completed | The Mediterranean Full-Fat Dairy Study NCT02781675 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | The Effect of 3-Week Consumption of Soya Beverage Enriched With Plant Sterols on Serum LDL-C NCT02881658 | The University of Hong Kong | N/A |
| Completed | Saturated Fatty Acids and HDL Metabolism NCT02835651 | Maastricht University Medical Center | N/A |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 NCT02753504 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients W NCT02642159 | Sanofi | Phase 4 |
| Terminated | Dose-response Study of Carduus Marianus in Centesimal Scale for Dyslipidemia in Climacteric Overweighed or Obe NCT02775448 | Hospital Nacional Homeopático, Mexico | Phase 2 |
| Withdrawn | Efficacy & Long-term Safety Comparison Study of NK-104-CR & Livalo® IR With Primary Hyperlipidemia or Mixed Dy NCT02799758 | Kowa Research Institute, Inc. | Phase 3 |
| Completed | Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia NCT02827903 | Jeil Pharmaceutical Co., Ltd. | Phase 3 |
| Withdrawn | Safety and Efficacy Comparison Study of NK-104-CR (Controled Release) in Patients With Primary Hyperlipidemia NCT02670434 | Kowa Research Institute, Inc. | Phase 3 |
| Completed | Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada NCT02537535 | Canadian Heart Research Centre | — |
| Completed | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 NCT02651753 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Clinical Trial of YH14755 in Subjects With Dyslipidemia and Type II Diabetes NCT02586129 | Yuhan Corporation | Phase 3 |
| Recruiting | The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardize NCT02726555 | Wenzhou Medical University | Phase 3 |
| Completed | The Effect of Meal Composition on Blood Lipids NCT02529709 | Texas Christian University | N/A |
| Completed | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. NCT02623868 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Terminated | Study Comparing Fish Oil and Krill Oil NCT02670356 | Tufts University | N/A |
| Completed | Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3) NCT02947620 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS) NCT02541201 | The University of Hong Kong | Phase 2 |
| Unknown | Low Calorie Diet and Diabetes NCT02498990 | Karolinska University Hospital | N/A |
| Completed | Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women NCT02727036 | Texas Woman's University | N/A |
| Completed | Rosuvastatin Adherence App Study in China NCT02433288 | AstraZeneca | N/A |
| Completed | The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia NCT02407548 | Sun Yat-sen University | Phase 3 |
| Completed | ADME Study in Healthy Male Subjects With TA-8995 NCT02408055 | Xention Ltd | Phase 1 |
| Completed | Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 NCT02484482 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Colesevelam, Lipids And Sugars, South Asian Canadian Trial NCT02504736 | Canadian Collaborative Research Network | — |
| Unknown | Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors NCT02716870 | University of Toronto | — |
| Completed | Fenofibrate Treatment in SCI NCT02455336 | VA Office of Research and Development | Phase 2 / Phase 3 |
| Completed | Cardiometabolic Response to a Sodium-bicarbonated Mineral Water NCT02480816 | National Research Council, Spain | N/A |
| Completed | Aging, Nitrate, Endothelial Function and Muscle Oxygenation NCT02772900 | Universidade Federal do Rio de Janeiro | N/A |
| Unknown | Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities NCT02459249 | Mexican National Institute of Public Health | N/A |
| Completed | Statins at the Primary Care Level NCT02380911 | Institute for Clinical Effectiveness and Health Policy | N/A |
| Completed | Atorvastatin Study in Cardiovascular Disease Risk NCT02392416 | Elpen Pharmaceutical Co. Inc. | — |
| Completed | The CREATE Wellness Study NCT02302612 | Kaiser Permanente | N/A |
| Completed | Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects NCT02207634 | Amgen | Phase 3 |
| Completed | The Hellenic Postprandial Lipemia Study (HPLS) NCT02163044 | Hellenic College of Treatment of Atherosclerosis | — |
| Unknown | Vascular Lifestyle-Intervention and Screening in Pharmacy NCT02223793 | University of Oslo | N/A |
| Unknown | Meta-analyses of the Effect of Legumes on Blood Pressure NCT02600338 | John Sievenpiper | — |
| Completed | Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 NCT02676830 | Kowa Research Institute, Inc. | Phase 1 |
| Completed | Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients NCT02364258 | Children's Mercy Hospital Kansas City | Phase 1 |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 NCT02156544 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Unknown | Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk NCT02702479 | University of Toronto | — |
| Completed | Bergamot and Cardio-Metabolic Risk Factors NCT02205567 | University of Palermo | — |
| Completed | Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16 NCT02808715 | National Heart Centre Singapore | — |
| Completed | A Study of Evacetrapib in Participants With Abnormal Cholesterol NCT02168803 | Eli Lilly and Company | Phase 1 |
| Completed | Gemigliptin-Rosuvastatin Fix-dose Combination Phase 3(BALANCE) NCT02126358 | LG Life Sciences | Phase 3 |
| Completed | Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/ NCT02442700 | Ramathibodi Hospital | Phase 4 |
| Completed | Stress and Sugar Synergy NCT02143011 | University of California, Davis | N/A |
| Completed | Soda and Milk Study NCT02094768 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients NCT02103049 | University Medical Centre Ljubljana | Phase 4 |
| Completed | Effects of a Probiotics on the Health of Normal Young Males NCT02230345 | Centre Hospitalier Universitaire Vaudois | N/A |
| Completed | Healthy Effects of an Innovative Probiotic Pasta NCT02236533 | University of Parma | N/A |
| Completed | Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe NCT02029625 | NVP Healthcare | Phase 1 |
| Unknown | An Intervention to Improve Management of Dyslipidemia in Primary Care NCT02438943 | The University of The West Indies | N/A |
| Unknown | Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes NCT02035644 | Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Completed | Impact of Consumption of Beta-glucans on the Intestinal Microbiota and Glucose and Lipid Metabolism NCT02041104 | Mlinotest Zivilska Industrija d.d. | N/A |
| Completed | Dyslipidemia and Diabetic Retinopathy NCT03403283 | University of Alabama at Birmingham | — |
| Completed | A Thorough Corrected QT Interval Trial NCT02073084 | Kowa Research Institute, Inc. | Phase 1 |
| Completed | Physiological Study of Human Cholesterol Metabolism and Excretion NCT01603758 | Richard E. Ostlund Jr., MD | Phase 1 |
| Terminated | Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia NCT01972178 | Pronova BioPharma | Phase 2 |
| Terminated | Is a Smartphone Application Effective as an Oral Medication Adherence Aid NCT01968876 | University of Arkansas | EARLY_Phase 1 |
| Unknown | Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study) NCT01972113 | Augusta University | N/A |
| Completed | Micronutrients and Health in Adult Chinese NCT04004143 | Shenzhen Center for Chronic Disease Control | — |
| Completed | TA-8995: Its Use in Patients With Mild Dyslipidaemia (TULIP) NCT01970215 | Xention Ltd | Phase 2 |
| Completed | The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects NCT01893515 | Pronova BioPharma | Phase 2 |
| Completed | Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia NCT01912560 | Catabasis Pharmaceuticals | Phase 2 |
| Terminated | Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia NCT01863225 | Resverlogix Corp | Phase 2 |
| Active Not Recruiting | Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk NCT02037321 | John Sievenpiper | — |
| Unknown | POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism i NCT03047668 | German Institute of Human Nutrition | N/A |
| Completed | Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis NCT01967355 | Karl Winkler | N/A |
| Completed | Effects of Almond Intake on Atherogenic Lipoprotein Particles NCT01792648 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese P NCT01760460 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslip NCT01420549 | Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Completed | Treatment of Overweight and Obese Children -Using the "Holbaek-Method" in a Municipality Based Treatment Progr NCT02013843 | Holbaek Sygehus | N/A |
| Withdrawn | A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, NCT01587235 | Organon and Co | Phase 4 |
| Completed | Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk NCT01764633 | Amgen | Phase 3 |
| Completed | Effects of Metformin on Hepatic FFA Metabolism NCT01729156 | Lars Christian Gormsen | Phase 4 |
| Completed | Development of a Novel Method to Study in Vivo Fatty Acid Metabolism Using Stable Isotope Labeled Fatty Acids NCT02312492 | Tufts University | N/A |
| Completed | Effect of Dietary Fatty Acids on Cardiovascular Disease Risk Indicators and Inflammation NCT02145936 | Tufts University | N/A |
| Completed | Effects of Niacin On Fatty Acid Trapping NCT01984073 | University of Pennsylvania | Phase 1 |
| Completed | A Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT- NCT01725594 | Catabasis Pharmaceuticals | Phase 1 |
| Completed | The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism NCT01564550 | University of Aarhus | — |
| Unknown | Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen NCT01705873 | Helios Salud | — |
| Completed | Clinical Study for Patients With Hypertension Associated With Dyslipidemia NCT01764295 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Completed | Feeding Trial to Determine How Combinations of Different Dietary Bioactive Ingredients Influence High Density NCT01803594 | University of California, Davis | N/A |
| Unknown | The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines NCT01101204 | Medical University of Silesia | N/A |
| Unknown | Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin NCT01613729 | D16 Pharma & Biotec Ltd. | Phase 4 |
| Completed | A 12-week Study to Compare the Efficacy and Safety of Fixed Combinations of Fenofibrate/Simvastatin 145/20mg a NCT01674712 | Abbott | Phase 3 |
| Completed | Alternative Treatments for Menopausal Women NCT02028702 | Aarhus University Hospital | N/A |
| Unknown | Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease NCT01608620 | John Sievenpiper | — |
| Completed | Effects of 5-day Statin Withdrawal on Endothelial Progenitor Cells and Inflammatory Markers in Type 2 Diabetic NCT01600690 | University of Padova | Phase 4 |
| Completed | Meta-analyses of the Effect of Tree Nuts on Glycemic Control and Features of the Metabolic Syndrome NCT01630980 | John Sievenpiper | — |
| Completed | Change of Fructose to Fat in South Asians NCT01562782 | The Rogosin Institute | N/A |
| Completed | Genetic Influences on Statin Blood Concentrations in African Americans NCT01569867 | Ohio State University | — |
| Unknown | Meta-analyses of Dietary Pulses and Cardiometabolic Risk NCT01594567 | John Sievenpiper | — |
| Completed | Beetroot Juice and Postprandial Vascular Activity NCT01559441 | Maastricht University Medical Center | N/A |
| Completed | Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2 NCT01958775 | University Health Network, Toronto | Phase 3 |
| Withdrawn | Genetic Influence on Statin Pharmacodynamics NCT01569854 | Ohio State University | — |
| Completed | Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1 NCT01458977 | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Phase 4 |
| Completed | Dietary Protein Sources and Atherogenic Dyslipidemia NCT01427855 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | Dietary Carbohydrate Type and Cardiovascular Disease (CVD) Risk Indicators NCT01610661 | Tufts University | N/A |
| Completed | Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia NCT02048410 | Federico II University | Phase 1 / Phase 2 |
| Completed | Dyslipidemia-related Risk Factors in Dialysis NCT02072837 | National and Kapodistrian University of Athens | — |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Pat NCT01487460 | Novartis Pharmaceuticals | Phase 1 |
| Completed | A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipid NCT01539616 | Zydus Lifesciences Limited | Phase 2 |
| Completed | Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic St NCT01474161 | Genfit | Phase 1 |
| Unknown | Thyroxin Treatment in Sub Clinical Hypothyroidism, on the Apnea Hypopnea Index Score, Lipids and Highly Sensit NCT01486667 | King Saud University | Phase 3 |
| Completed | Reduction of Sweetened Beverages and Intrahepatic Fat NCT01394380 | University of Lausanne | N/A |
| Completed | Effect of Nigella Sativa on Lipid Profiles in Elderly NCT01531062 | Indonesia University | Phase 2 |
| Terminated | Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) NCT01414166 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Brazil Nut Consumption in Microvascular Endothelial Function, Oxidative Stress and Metabolic Abnormalities NCT01990391 | Universidade Federal do Rio de Janeiro | N/A |
| Completed | The Study of Quantitative Serial Trends in Lipids With ApolpoproteinA-I Stimulation NCT01423188 | Resverlogix Corp | Phase 2 |
| Completed | Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease NCT01422421 | Takeshi Morimoto | Phase 4 |
| Completed | Cholesterol Goal Attainment Rate and Its Associated Factors Among Dyslipidemic Patients on Lipid-lowering Drug NCT01372956 | AstraZeneca | — |
| Completed | A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants W NCT01333436 | Organon and Co | N/A |
| Completed | Live Well: A Practical and Effective Low-Intensity Dietary Counseling Intervention for Use in Primary Care Pat NCT01695837 | University of Nevada, Las Vegas | N/A |
| Completed | Exploring the Molecular Basis to Healthy Obesity: The Diabetes Risk Assessment Study NCT01884714 | University of Guelph | N/A |
| Completed | Effects of High Fruit, Vegetable, and Dairy Intake on Plasma Lipids and Blood Pressure in Healthy Individuals NCT01404897 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | Africa and Middle East Cardiovascular Epidemiological Study NCT01243138 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Completed | A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins NCT01342211 | Pfizer | Phase 2 |
| Unknown | Longitudinal Study of Multi-Analyte Profile for Dyslipidemia NCT01441908 | MaiHealth Inc | N/A |
| Completed | Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia NCT01402843 | JW Pharmaceutical | Phase 3 |
| Completed | Micro-Clinic Obesity and Metabolic Risk Prevention Program NCT01651065 | Microclinic International | N/A |
| Completed | A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins NCT01350141 | Pfizer | Phase 2 |
| Completed | The Effects of Orange Juice on Plasma Lipids NCT01350843 | University of Nottingham | N/A |
| Withdrawn | Dyslipidemia Treatment in Thailand and Cardiovascular Outcomes NCT01265836 | AstraZeneca | — |
| Withdrawn | Observational Study To Evaluate Statins Patterns Of Use In Spain NCT01023503 | AstraZeneca | — |
| Terminated | A Study to Evaluate Efficacy and Safety of Extended-Release Niacin + Laropiprant + Simvastatin in Participants NCT01294683 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Effects of Water-Based Exercise on Lipid Profile and Lipoprotein Lipase of Dyslipidemic Premenopausal Women NCT02418715 | Hospital de Clinicas de Porto Alegre | N/A |
| Completed | Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia NCT01243151 | Pfizer | Phase 1 |
| Completed | Management of Dyslipidemia in Adult Type 2 Diabetes Patients in India NCT01292018 | AstraZeneca | — |
| Completed | Tailored Communication to Reduce Cardiovascular Risk NCT01286311 | Northwestern University | N/A |
| Completed | Resveratrol and Serum Apo A-I NCT01364961 | Maastricht University Medical Center | N/A |
| Completed | Prevalence of Subclinical Atherosclerosis and Its Associated Factors in Hyperlipidemic Korean Adults With Diab NCT01264263 | AstraZeneca | — |
| Unknown | Supplementation With Flaxseed Oil in the State of Rio de Janeiro NCT01604681 | Universidade Federal do Rio de Janeiro | N/A |
| Completed | A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects NCT01301066 | Kowa Research Institute, Inc. | Phase 4 |
| Completed | A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either N NCT01262638 | Esperion Therapeutics, Inc. | Phase 2 |
| Completed | Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy NCT01239004 | Radiant Research | Phase 4 |
| Completed | Efficacy Study of Diazoxide Choline to Treat Hypertriglyceridemia NCT01211847 | Essentialis, Inc. | Phase 2 |
| Withdrawn | Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia NCT01163838 | Pfizer | Phase 1 |
| Terminated | The Impact of Tredaptive on Flow-Mediated Dilation in Cardiac Patients NCT01052311 | Sheba Medical Center | Phase 4 |
| Completed | Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvast NCT01163851 | Pfizer | Phase 1 |
| Completed | Improving Adherence to Statins Among Minority Populations NCT02037685 | University of Miami | N/A |
| Completed | Pharmacokinetics of Anacetrapib (MK0859) in Subjects With Impaired Renal Function (MK-0859-038) NCT01122667 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Safety Study of BMS-823778 in Subjects With Hypercholesterolemia NCT01112423 | Bristol-Myers Squibb | Phase 2 |
| Completed | Safety Study of BMS-770767 in Subjects With Hypercholesterolemia NCT01058083 | Bristol-Myers Squibb | Phase 2 |
| Completed | Pharmacokinetics of Anacetrapib (MK0859) in Patients With Hepatic Insufficiency (MK-0859-039) NCT01114490 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | A Study of LY2484595 in Patients With High LDL-C or Low HDL-C NCT01105975 | Eli Lilly and Company | Phase 2 |
| Completed | The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort NCT03191227 | University College Cork | — |
| Completed | Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk Factors NCT01883401 | Oklahoma State University | N/A |
| Completed | A Study on Postmarketing Xuezhikang Capsule for Treating Dyslipidemia NCT02057302 | China Academy of Chinese Medical Sciences | Phase 4 |
| Completed | Additional KIF6 Risk Offers Better Adherence to Statins NCT01068834 | Medco Health Solutions, Inc. | — |
| Completed | Hepatic Insulin Sensitivity and Very Low Density Lipoprotein Triglyceride (VLDL-TG) Kinetics NCT01205750 | University of Aarhus | N/A |
| Completed | Study of A3309 in Patients With Dyslipidemia NCT01069783 | Albireo | Phase 2 |
| Completed | Effects of Niaspan™ on High-density Lipoprotein (HDL) in Healthy Male Subjects (0000-069) NCT01071291 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Study of Undertreatment of Patients With Dyslipidemia in Bulgaria NCT01075594 | AstraZeneca | — |
| Completed | Observational Study to Estimate the Rates of Outcomes in Patients Undergoing Percutaneous Coronary Interventio NCT01047176 | AstraZeneca | — |
| Completed | Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis NCT01019200 | George Washington University | — |
| Completed | Safety Study of BMS-816336 in Healthy Male Subjects NCT00979368 | Bristol-Myers Squibb | Phase 1 |
| Completed | Cardiovascular Events Based On Statin Initiation In The Elderly NCT01304641 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | — |
| Terminated | Study of Trilipix Effects on Lipids and Arteries NCT01025492 | University of Utah | Phase 4 |
| Completed | The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3) NCT00990808 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | The Roles of SAH Gene Family in Athrogenic Dyslipidemia in Postmenopausal Women NCT00945217 | Taipei Veterans General Hospital, Taiwan | — |
| Completed | A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0 NCT00961636 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Treatment With Nutritional Eating Plan and Dietary Fibers in Adult Patients With HIV/AIDS NCT02180035 | Conselho Nacional de Desenvolvimento Científico e Tecnológico | N/A |
| Unknown | Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niaci NCT01010516 | University of Ioannina | Phase 4 |
| Unknown | HIV Reverse Cholesterol Transport Study NCT01670968 | University College Dublin | — |
| Completed | A Study of Safety and Efficacy of MK0859 (Anacetrapib) in Japanese Patients With Dyslipidemia (0859-029) NCT00977288 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Change in Plaque Characteristics With Atorvastatin NCT00700037 | Wakayama Medical University | Phase 4 |
| Completed | Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 After Multiple Doses in H NCT01879020 | Tanabe Pharma Corporation | Phase 1 |
| Unknown | Meta-analyses of Fructose and Cardiometabolic Risk NCT01363791 | John Sievenpiper | — |
| Completed | Efficiency of Rosuvastatin Versus the Fixed Combination of Ezetimibe/Simvastatin in Outpatients NCT01164397 | AstraZeneca | — |
| Completed | Effect of Saturated Fat on Large Low-density Lipoprotein (LDL) and High-density Lipoprotein (HDL) NCT00895141 | UCSF Benioff Children's Hospital Oakland | N/A |
| Completed | Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatm NCT02153879 | Institut Investigacio Sanitaria Pere Virgili | Phase 4 |
| Completed | Effects of Simvastatin and Ezetimibe on Cardiovascular Risk Markers in Patients With Dyslipidemia NCT02304926 | Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana | N/A |
| Completed | Study of Lipid Control in Hyperlipidemic Participants (MK-0653-179) NCT01436253 | Organon and Co | — |
| Completed | A Study to Design a Model Cohort for Analysis of Dyslipidemia (MK-0653A-204) NCT01414192 | Organon and Co | — |
| Completed | Effect of a Treatment of Lifestyle Changes on the Prevalence of Metabolic Syndrome and Body Weight in Mexican NCT02247635 | Mexican National Institute of Public Health | N/A |
| Completed | Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity NCT01806506 | Medical University of Warsaw | N/A |
| Completed | Metformin for Treatment of Antipsychotic-induced Dyslipidemia NCT01778244 | Central South University | Phase 4 |
| Completed | The Metabolic Effects of Consuming Sugar-Sweetened Beverages for Two Weeks NCT01103921 | University of California, Davis | N/A |
| Completed | Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol NCT00768274 | Resverlogix Corp | Phase 1 / Phase 2 |
| Completed | The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia NCT01285544 | Seoul National University Hospital | Phase 4 |
| Withdrawn | Extended Release (ER) Niacin/Laropiprant Add on Study (0524A-082) NCT00664287 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic NCT00708370 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Phase 4 |
| Completed | Association of Genes to Resistance to Weight Loss in Obese Patients NCT00858221 | Interleukin Genetics, Inc. | — |
| Completed | Dyslipidemia in Cardiovascular Disease NCT01029522 | Chong Kun Dang Pharmaceutical | Phase 4 |
| Completed | A Study of the Kinetics of a 13C-Cholesterol Infusate in Healthy Male Subjects (0000-108)(COMPLETED) NCT01101763 | Merck Sharp & Dohme LLC | — |
| Unknown | Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickn NCT00712049 | Medical University of Vienna | Phase 4 |